Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13969330 | 0.88 | ALDH1A1 (0.30) | — | |
| SCHEMBL6892231 | 0.87 | ELANE (0.33) | ELANE | |
| SCHEMBL13946276 | 0.87 | ELANE (0.33) | ELANE | |
| SCHEMBL9726095 | 0.87 | ELANE (0.33) | ELANE | |
| SCHEMBL7630397 | 0.86 | ELANE (0.31) | ELANE | |
| SCHEMBL9428848 | 0.85 | ELANE (0.31) | ELANE | |
| SCHEMBL9428362 | 0.85 | FAAH (0.32) | ELANE | |
| SCHEMBL6892042 | 0.84 | FAAH (0.33) | ELANE | |
| SCHEMBL3873801 | 0.84 | FAAH (0.33) | ELANE | |
| SCHEMBL13764795 | 0.84 | FAAH (0.33) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7482445-B2 | Crystalline carbapenem intermediate | MEIJI SEIKA KAISHA, LTD. (JP) | 2009-01-27 | — | — | US | disclosed |
| US-20070167620-A1 | Crystalline carbapenem intermediate | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167620-A1 | Crystalline carbapenem intermediate | TBKBP1, RPS6KB1, TNKS1BP1 | ELANE 3808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.